• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童时期接受干细胞移植治疗的成年人的肾小球和肾小管功能。

Glomerular and tubular function in young adults treated with stem-cell transplantation in childhood.

机构信息

Unit of Pediatric Oncology, Children's Hospital, Uppsala, Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

出版信息

Pediatr Nephrol. 2010 Jul;25(7):1337-42. doi: 10.1007/s00467-010-1501-6. Epub 2010 Apr 8.

DOI:10.1007/s00467-010-1501-6
PMID:20376502
Abstract

We evaluated renal function at a median follow-up of 18 (range 10.3-22.1) years after total body irradiation in 18 patients treated with stem-cell transplantation (SCT) (autologous SCT in 15 and allogeneic SCT in three) for hematologic malignancies and compared them with 18 healthy controls. No patient had chronic graft-versus-host disease. We found no difference in glomerular filtration rate estimated from cystatin C (105 vs 111 ml/min/1.73 m(2), p = 0.28). Patients had higher albumin excretion (0.8 vs 0.4 mg/mmol, p = 0.001), but no patient had overt albuminuria (>200 mg/L). Patients had higher diastolic blood pressure (74 vs 67 mmHg, p = 0.003). Two patients (11%) had hypertension. Patients had lower tubular reabsorption of phosphate (0.78 vs 0.91 mmol/L, p = 0.014) and higher excretion of alpha-1-microglobulin (AMG/urine creatinine, 0.4 vs 0.25 mg/mmol, p = 0.038), which correlated with time after SCT (r = 0.6, p = 0.01). We found no difference in fractional excretion (FE) of other electrolytes, amino acid excretion, or urine osmolality. We conclude that renal function was relatively well preserved at a median follow-up of 18 years after childhood SCT. The higher albumin excretion in our patients is of concern, as is the association between excretion of AMG and time after SCT, suggesting that both glomerular and tubular function may deteriorate further.

摘要

我们评估了 18 名接受干细胞移植(SCT)治疗血液系统恶性肿瘤的患者(15 名自体 SCT,3 名异基因 SCT)在总身体照射后中位数为 18 年(范围 10.3-22.1)的肾功能,并与 18 名健康对照进行了比较。没有患者患有慢性移植物抗宿主病。我们发现胱抑素 C 估算的肾小球滤过率无差异(105 与 111 ml/min/1.73 m(2),p = 0.28)。患者的白蛋白排泄量较高(0.8 与 0.4 mg/mmol,p = 0.001),但没有患者出现显性蛋白尿(>200 mg/L)。患者的舒张压较高(74 与 67 mmHg,p = 0.003)。两名患者(11%)患有高血压。患者的磷酸盐肾小管重吸收率较低(0.78 与 0.91 mmol/L,p = 0.014),α-1-微球蛋白(AMG/尿肌酐)排泄量较高(0.4 与 0.25 mg/mmol,p = 0.038),与 SCT 后时间相关(r = 0.6,p = 0.01)。我们没有发现其他电解质、氨基酸排泄或尿渗透压的排泄分数(FE)有差异。我们得出结论,在儿童 SCT 后中位数为 18 年的随访中,肾功能相对较好地得到了保留。我们患者的白蛋白排泄较高令人担忧,AMG 的排泄与 SCT 后时间之间的相关性表明肾小球和肾小管功能可能进一步恶化。

相似文献

1
Glomerular and tubular function in young adults treated with stem-cell transplantation in childhood.儿童时期接受干细胞移植治疗的成年人的肾小球和肾小管功能。
Pediatr Nephrol. 2010 Jul;25(7):1337-42. doi: 10.1007/s00467-010-1501-6. Epub 2010 Apr 8.
2
Chronic kidney disease after nonmyeloablative stem cell transplantation in adults.成人非清髓性干细胞移植后的慢性肾脏病
Biol Blood Marrow Transplant. 2008 Apr;14(4):403-8. doi: 10.1016/j.bbmt.2007.12.495.
3
Tubular and glomerular function in children after renal transplantation.儿童肾移植后的肾小管和肾小球功能
Pediatr Transplant. 2005 Aug;9(4):440-4. doi: 10.1111/j.1399-3046.2005.00302.x.
4
Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy?儿童1型糖尿病病程早期肾小球滤过率增加或肾小管功能紊乱是否可预测肾病的发生?
Diabet Med. 1992 Aug-Sep;9(7):635-40. doi: 10.1111/j.1464-5491.1992.tb01859.x.
5
Long-term renal function following bone marrow transplantation.骨髓移植后的长期肾功能
Bone Marrow Transplant. 2007 Jun;39(11):717-23. doi: 10.1038/sj.bmt.1705662.
6
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.清髓性与常规强度预处理异基因造血干细胞移植治疗急性淋巴细胞白血病的回顾性研究:来自欧洲血液和骨髓移植学会的研究
Blood. 2010 Nov 25;116(22):4439-43. doi: 10.1182/blood-2010-02-266551. Epub 2010 Aug 17.
7
Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT).异基因干细胞移植(SCT)前进行分次全身照射(TBI)后儿童的长期肾脏毒性。
Strahlenther Onkol. 2009 Nov;185(11):751-5. doi: 10.1007/s00066-009-2022-8. Epub 2009 Nov 10.
8
Renal function after conditioning therapy for bone marrow transplantation in childhood.儿童骨髓移植预处理治疗后的肾功能
Med Pediatr Oncol. 1997 Apr;28(4):274-83. doi: 10.1002/(sici)1096-911x(199704)28:4<274::aid-mpo6>3.0.co;2-f.
9
The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.B 系急性淋巴细胞白血病异基因干细胞移植后,急性和慢性移植物抗宿主病对正常及恶性 B 淋巴细胞前体的影响
Haematologica. 2006 Mar;91(3):340-7.
10
Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.清髓性异基因造血干细胞移植后的慢性肾脏病
Biol Blood Marrow Transplant. 2007 Oct;13(10):1169-75. doi: 10.1016/j.bbmt.2007.06.008. Epub 2007 Jul 27.

引用本文的文献

1
Long-term kidney complications in childhood leukemia survivors: a study from the Childhood and Adolescent Leukemia (LEA) project.儿童白血病幸存者的长期肾脏并发症:来自儿童和青少年白血病(LEA)项目的一项研究。
Haematologica. 2025 Sep 1;110(9):1987-1997. doi: 10.3324/haematol.2024.286940. Epub 2025 Apr 3.
2
Teenagers and young adults with a past of allogenic hematopoietic stem cell transplantation are at significant risk of chronic kidney disease.接受过异基因造血干细胞移植的青少年和年轻人有发生慢性肾脏病的重大风险。
Pediatr Nephrol. 2022 Jun;37(6):1365-1375. doi: 10.1007/s00467-021-05319-x. Epub 2021 Nov 4.

本文引用的文献

1
Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.儿童造血细胞移植后长期生存者的高血压。
Biol Blood Marrow Transplant. 2010 Apr;16(4):515-24. doi: 10.1016/j.bbmt.2009.11.018. Epub 2009 Dec 2.
2
Long-term evaluation of Ifosfamide-related nephrotoxicity in children.儿童异环磷酰胺相关肾毒性的长期评估。
J Clin Oncol. 2009 Nov 10;27(32):5350-5. doi: 10.1200/JCO.2008.17.5257. Epub 2009 Oct 13.
3
Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
异基因造血干细胞移植后2年仍存活且未复发患者的慢性肾功能不全
Biol Blood Marrow Transplant. 2009 Oct;15(10):1251-7. doi: 10.1016/j.bbmt.2009.05.016.
4
Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.在雅培Ci8200上对龙胆胱抑素C试剂进行评估,并根据胱抑素C值(单位为mg/L)计算以mL/min/1.73 m²表示的肾小球滤过率。
Scand J Clin Lab Invest. 2007;67(5):560-7. doi: 10.1080/00365510601187773.
5
Long-term renal function following bone marrow transplantation.骨髓移植后的长期肾功能
Bone Marrow Transplant. 2007 Jun;39(11):717-23. doi: 10.1038/sj.bmt.1705662.
6
Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review.胱抑素C能否替代肌酐来估算肾小球滤过率?一篇文献综述。
Am J Nephrol. 2007;27(2):197-205. doi: 10.1159/000100907. Epub 2007 Mar 15.
7
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis.与血清肌酐相比,胱抑素C在评估成人和儿童肾功能不全中的诊断准确性——一项荟萃分析。
Clin Biochem. 2007 Mar;40(5-6):383-91. doi: 10.1016/j.clinbiochem.2006.10.026. Epub 2007 Jan 5.
8
Chronic kidney disease in long-term survivors of hematopoietic cell transplant.造血细胞移植长期存活者中的慢性肾脏病
Bone Marrow Transplant. 2007 Feb;39(4):223-9. doi: 10.1038/sj.bmt.1705573.
9
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).造血细胞移植后长期存活者的推荐筛查及预防措施:欧洲血液与骨髓移植组、国际血液与骨髓移植研究中心及美国血液与骨髓移植学会(EBMT/CIBMTR/ASBMT)联合推荐
Bone Marrow Transplant. 2006 Feb;37(3):249-61. doi: 10.1038/sj.bmt.1705243.
10
Long-term renal function after hemopoietic stem cell transplantation in children.儿童造血干细胞移植后的长期肾功能
Bone Marrow Transplant. 2005 Oct;36(7):605-10. doi: 10.1038/sj.bmt.1705110.